Patents by Inventor Yunjiao HE

Yunjiao HE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240014274
    Abstract: A terminal structure of a bidirectional switching device, where the terminal structure can include: a field plate located on a top surface of a well region and between a first voltage-withstand region and a second voltage-withstand region, where the bidirectional switching device comprises the well region, and the first and second voltage-withstand regions located in the well region; and where a potential is connected to the field plate, in order to decrease an electrical leakage of a parasitic transistor, where the parasitic transistor is formed by the first voltage-withstand region, the well region, and the second voltage-withstand region.
    Type: Application
    Filed: June 26, 2023
    Publication date: January 11, 2024
    Inventors: Nan Chen, Yicheng Du, Pengfei Yin, Meng Wang, Kai Zhang, Hao Zhu, Xi Zhou, Yunjiao He
  • Patent number: 10618939
    Abstract: The present invention relates to a Beclin 1-UVRAG complex structure which reveals a tightly packed coiled coil assembly with Beclin 1 and UVRAG residues complementing each other to form a stable dimeric complex. This potent physical interaction is critical for UVRAG-dependent EGFR degradation but less critical for autophagy. Targeting the Beclin 1 coiled coil domain with rationally designed stapled peptides leads to enhanced autophagy activity and EGFR degradation in non-small cell lung cancer (NSCLC) cell lines, suggesting translational value for these compounds.
    Type: Grant
    Filed: March 14, 2018
    Date of Patent: April 14, 2020
    Assignee: The Hong Kong Polytechnic University
    Inventors: Yanxiang Zhao, Shuai Wu, Wenchao Yang, Yunjiao He, Xiaohua Li, Xianxiu Qiu
  • Publication number: 20180208627
    Abstract: The present invention relates to a Beclin 1-UVRAG complex structure which reveals a tightly packed coiled coil assembly with Beclin 1 and UVRAG residues complementing each other to form a stable dimeric complex. This potent physical interaction is critical for UVRAG-dependent EGFR degradation but less critical for autophagy. Targeting the Beclin 1 coiled coil domain with rationally designed stapled peptides leads to enhanced autophagy activity and EGFR degradation in non-small cell lung cancer (NSCLC) cell lines, suggesting translational value for these compounds.
    Type: Application
    Filed: March 14, 2018
    Publication date: July 26, 2018
    Inventors: Yanxiang ZHAO, Shuai WU, Wenchao YANG, Yunjiao HE, Xiaohua LI, Xianxiu QIU
  • Publication number: 20180002381
    Abstract: The present invention relates to a Beclin1-UVRAG complex structure which reveals a tightly packed coiled coil assembly with Beclin 1 and UVRAG residues complementing each other to form a stable dimeric complex. This potent physical interaction is critical for UVRAG-dependent EGFR degradation but less critical for autophagy. Targeting the Beclin coiled coil domain with rationally designed stapled peptides leads to enhanced autophagy activity and EGFR degradation in non-small cell lung cancer (NSCLC) cell lines, suggesting translational value for these compounds.
    Type: Application
    Filed: June 29, 2017
    Publication date: January 4, 2018
    Inventors: Yanxiang ZHAO, Shuai WU, Wenchao YANG, Yunjiao HE, Xiaohua LI, Xianxiu QIU